Alpha 2.0
Login Register
» Authors » S Nigen

S Nigen

Explore the profile of S Nigen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 127
Followers 0
Related Specialties
Infectious Diseases
Dermatology
Biomedical Engineering
Top 10 Co-Authors
R Bissonnette
C Bolduc
C Maari
Y Poulin
C W Lynde
N Provost
J E Risch
L Tang
K J McElwee
J Z Li
Published In
J Eur Acad Dermatol Venereol
J Biomech Eng
J Drugs Dermatol
Skin Res Technol
J Cosmet Dermatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Changes in serum free testosterone, sleep patterns, and 5-alpha-reductase type I activity influence changes in sebum excretion in female subjects
Bissonnette R, Risch J, McElwee K, Marchessault P, Bolduc C, Nigen S, et al.
Skin Res Technol . 2014 Aug; 21(1):47-53. PMID: 25163854
Background/purpose: Sebum is thought to play an important role in acne vulgaris and sebum excretion rate (SER) is often used as a marker of efficacy in acne studies. This study...
2.
Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial
Bissonnette R, Nigen S, Langley R, Lynde C, Tan J, Fuentes-Duculan J, et al.
J Eur Acad Dermatol Venereol . 2013 Oct; 28(10):1298-305. PMID: 24112799
Background: Palmo-plantar pustular psoriasis (PPPP) and palmo-plantar pustulosis (PPP) are chronic skin diseases with significant impact on quality of life. Objectives: The purpose of this study was to study the...
3.
Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial
Bissonnette R, Bolduc C, Maari C, Nigen S, Webster J, Tang L, et al.
J Eur Acad Dermatol Venereol . 2011 Nov; 26(12):1516-21. PMID: 22077962
Background: There is a need for the development of novel non-steroidal topical drugs for the treatment of psoriasis. Objective: To assess the efficacy and safety of topical 1.0% WBI-1001 in...
4.
Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study
Bissonnette R, Poulin Y, Guenther L, Lynde C, Bolduc C, Nigen S
J Eur Acad Dermatol Venereol . 2011 Feb; 25(12):1402-8. PMID: 21349113
Background: Palmoplantar psoriasis is a difficult to treat variant of plaque psoriasis. Objective: To study the safety and efficacy of infliximab in non-pustular palmoplantar psoriasis. Methods: Patients with non-pustular palmoplantar...
5.
Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris
Bissonnette R, Bolduc C, Seite S, Nigen S, Provost N, Maari C, et al.
J Cosmet Dermatol . 2009 Mar; 8(1):19-23. PMID: 19250161
Background: New topical treatments for acne vulgaris are needed for patients who have tolerance problems with current treatments. Aims: To compare the efficacy and tolerance of a lipophillic derivative of...
6.
Etanercept in the treatment of palmoplantar pustulosis
Bissonnette R, Poulin Y, Bolduc C, Maari C, Provost N, Syrotuik J, et al.
J Drugs Dermatol . 2008 Dec; 7(10):940-6. PMID: 19112757
Introduction: Palmoplantar pustulosis (PPP) is a chronic, recurrent and difficult to treat skin condition characterized by the presence of pustules, erythema, and hyperkeratosis on palms and soles. Methods: Fifteen subjects...
7.
Modified Bilston nonlinear viscoelastic model for finite element head injury studies
Shen F, Tay T, Li J, Nigen S, Lee P, Chan H
J Biomech Eng . 2006 Sep; 128(5):797-801. PMID: 16995770
This paper proposes a modified nonlinear viscoelastic Bilston model (Bilston et al., 2001, Biorheol., 38, pp. 335-345). for the modeling of brain tissue constitutive properties. The modified model can be...